Brief: Imricor Medical Systems Granted ASX Waiver From Listing Rules Effective 26 May
27/05/2026 02:23
May 27 (Reuters) - Imricor Medical Systems IncIMR.AX : * GRANTING OF ASX WAIVER - US FINANCIAL REPORTING REQUIREMENTS * GRANTED ASX WAIVER FROM LISTING RULES EFFECTIVE 26 MAY 2026 * WAIVER ALIGNS IMRICOR ASX REPORTING WITH U.S. REQUIREMENTS Further company coverage:IMR.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion